BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 9367172)

  • 1. Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody.
    Sheu JR; Yen MH; Kan YC; Hung WC; Chang PT; Luk HN
    Biochim Biophys Acta; 1997 Oct; 1336(3):445-54. PubMed ID: 9367172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits human cervical carcinoma (HeLa) cell-substratum adhesion through an RGD-dependent mechanism.
    Sheu JR; Lin CH; Peng HC; Huang TF
    Peptides; 1994; 15(8):1391-8. PubMed ID: 7700842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits the adhesion of tumor cells to matrix proteins via binding to multiple integrin receptors expressed on human hepatoma cells.
    Sheu JR; Lin CH; Peng HC; Huang TF
    Proc Soc Exp Biol Med; 1996 Oct; 213(1):71-9. PubMed ID: 8820826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triflavin inhibits platelet-induced vasoconstriction in de-endothelialized aorta.
    Sheu JR; Yen MH; Hung WC; Lee YM; Su CH; Huang TF
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3461-8. PubMed ID: 9437193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triflavin, an antiplatelet peptide, inhibits tumor cell-extracellular matrix adhesion through an arginine-glycine-aspartic acid-dependent mechanism.
    Sheu JR; Lin CH; Huang TF
    J Lab Clin Med; 1994 Feb; 123(2):256-63. PubMed ID: 8301202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist.
    Kumar CC; Malkowski M; Yin Z; Tanghetti E; Yaremko B; Nechuta T; Varner J; Liu M; Smith EM; Neustadt B; Presta M; Armstrong L
    Cancer Res; 2001 Mar; 61(5):2232-8. PubMed ID: 11280792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contortrostatin, a homodimeric snake venom disintegrin, is a potent inhibitor of osteoclast attachment.
    Mercer B; Markland F; Minkin C
    J Bone Miner Res; 1998 Mar; 13(3):409-14. PubMed ID: 9525341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triflavin, an Arg-Gly-Asp-containing antiplatelet peptide inhibits cell-substratum adhesion and melanoma cell-induced lung colonization.
    Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
    Jpn J Cancer Res; 1992 Aug; 83(8):885-93. PubMed ID: 1399825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accutin, a new disintegrin, inhibits angiogenesis in vitro and in vivo by acting as integrin alphavbeta3 antagonist and inducing apoptosis.
    Yeh CH; Peng HC; Huang TF
    Blood; 1998 Nov; 92(9):3268-76. PubMed ID: 9787163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v)beta(3) blockade of endothelial cells.
    Yeh CH; Peng HC; Yang RS; Huang TF
    Mol Pharmacol; 2001 May; 59(5):1333-42. PubMed ID: 11306719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triflavin, an Arg-Gly-Asp containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line.
    Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
    Thromb Res; 1992 Jun; 66(6):679-91. PubMed ID: 1519227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of endothelial cell differential attachment to fibrin and fibrinogen and its inhibition by Arg-Gly-Asp-containing peptides.
    Chang MC; Wang BR; Huang TF
    Thromb Haemost; 1995 Aug; 74(2):764-9. PubMed ID: 8585019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone sialoprotein mediates human endothelial cell attachment and migration and promotes angiogenesis.
    Bellahcène A; Bonjean K; Fohr B; Fedarko NS; Robey FA; Young MF; Fisher LW; Castronovo V
    Circ Res; 2000 Apr; 86(8):885-91. PubMed ID: 10785511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel disintegrin salmosin inhibits tumor angiogenesis.
    Kang IC; Lee YD; Kim DS
    Cancer Res; 1999 Aug; 59(15):3754-60. PubMed ID: 10446992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor, on anti-angiogenesis and anti-tumor activities.
    Sheu JR; Fu CC; Tsai ML; Chung WJ
    Anticancer Res; 1998; 18(6A):4435-41. PubMed ID: 9891506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines modulate integrin alpha(v)beta(3)-mediated human endothelial cell adhesion and calcium signaling.
    Yeh CH; Peng HC; Huang TF
    Exp Cell Res; 1999 Aug; 251(1):57-66. PubMed ID: 10438571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of angiogenesis properties by SZ-21].
    Sheng M; Hu XH; Ruan CG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):74-80. PubMed ID: 12667295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of retinal pigment epithelial cell-induced tractional retinal detachment by disintegrins, a group of Arg-Gly-Asp-containing peptides from viper venom.
    Yang CH; Huang TF; Liu KR; Chen MS; Hung PT
    Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):843-54. PubMed ID: 8603869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterophilic interactions between cell adhesion molecule L1 and alphavbeta3-integrin induce HUVEC process extension in vitro and angiogenesis in vivo.
    Hall H; Djonov V; Ehrbar M; Hoechli M; Hubbell JA
    Angiogenesis; 2004; 7(3):213-23. PubMed ID: 15609076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiolutin, an inhibitor of HUVEC adhesion to vitronectin, reduces paxillin in HUVECs and suppresses tumor cell-induced angiogenesis.
    Minamiguchi K; Kumagai H; Masuda T; Kawada M; Ishizuka M; Takeuchi T
    Int J Cancer; 2001 Aug; 93(3):307-16. PubMed ID: 11433393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.